Skip to main content
. 2022 Aug 1;12(8):1175. doi: 10.3390/life12081175

Table 1.

Demography of the patients (n = 65).

Mean ± SD
Age 60.8 ± 14.9
Sex M 22 (33.8%)
F 43 (66.2%)
WBC/ul 7160 ± 1294
N/L (ratio) 2.68 ± 0.56
History of embolization 7 (10.8%)
Follow-up periods (months) 97.7 ± 52.9
Onset to treatment (months) 4.77 ± 6.31
Symptom/signs Red eye 60 (92.3%)
Increases IOP 26 (40%)
Cranial nerve palsy 21 (32.7%)
Location of symptom Right 17 (26.2%)
Left 37 (56.9%)
Bilateral 11 (16.9%)
Location of fistula Right 23 (35.4%)
left 26 (40%)
bilateral 16 (24.6%)
Barrow classification B 4 (6.1%)
C 2 (3.1%)
D 59 (90.8%)
Target volume (cc) 2 ± 1.43
Margin dose (Gy) 18 ± 0.79
Maximum dose (Gy) 32.75 ± 3.65
Maximum error in angiography (mm) 0.12 ± 0.04
Isodose line (%) 55 ± 5.5
Conformity index 1.28 ± 0.08
Number of isocenters 5.4 ± 3.6

Data are presented as mean± standard deviation. N/L: neutrophil/lymphocyte.